These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 31962142)
1. Dormant tumor cells interact with memory CD8 Flores-Guzmán F; Utikal J; Umansky V Cancer Lett; 2020 Apr; 474():74-81. PubMed ID: 31962142 [TBL] [Abstract][Full Text] [Related]
2. Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors. Umansky V; Abschuetz O; Osen W; Ramacher M; Zhao F; Kato M; Schadendorf D Cancer Res; 2008 Nov; 68(22):9451-8. PubMed ID: 19010920 [TBL] [Abstract][Full Text] [Related]
3. Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells. Umansky V; Sevko A Pigment Cell Melanoma Res; 2013 Jul; 26(4):457-63. PubMed ID: 23560814 [TBL] [Abstract][Full Text] [Related]
4. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma. Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189 [TBL] [Abstract][Full Text] [Related]
5. Effect of artesunate on immune cells in ret-transgenic mouse melanoma model. Ramacher M; Umansky V; Efferth T Anticancer Drugs; 2009 Nov; 20(10):910-7. PubMed ID: 19745721 [TBL] [Abstract][Full Text] [Related]
6. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells. Pommier A; Audemard A; Durand A; Lengagne R; Delpoux A; Martin B; Douguet L; Le Campion A; Kato M; Avril MF; Auffray C; Lucas B; Prévost-Blondel A Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13085-90. PubMed ID: 23878221 [TBL] [Abstract][Full Text] [Related]
8. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma. Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells. Letsch A; Keilholz U; Assfalg G; Mailänder V; Thiel E; Scheibenbogen C Cancer Res; 2003 Sep; 63(17):5582-6. PubMed ID: 14500398 [TBL] [Abstract][Full Text] [Related]
10. Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer. Ge Y; Böhm HH; Rathinasamy A; Xydia M; Hu X; Pincha M; Umansky L; Breyer C; Hillier M; Bonertz A; Sevko A; Domschke C; Schuetz F; Frebel H; Dettling S; Herold-Mende C; Reissfelder C; Weitz J; Umansky V; Beckhove P Cancer Immunol Res; 2019 Dec; 7(12):1998-2012. PubMed ID: 31672785 [TBL] [Abstract][Full Text] [Related]
11. GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology. Lin GH; Snell LM; Wortzman ME; Clouthier DL; Watts TH J Immunol; 2013 May; 190(9):4627-39. PubMed ID: 23536631 [TBL] [Abstract][Full Text] [Related]
12. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma. Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277 [TBL] [Abstract][Full Text] [Related]
13. Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation. Umansky V; Sevko A Cancer Immunol Immunother; 2012 Feb; 61(2):275-282. PubMed ID: 22120757 [TBL] [Abstract][Full Text] [Related]
14. Resident memory CD8 Molodtsov AK; Khatwani N; Vella JL; Lewis KA; Zhao Y; Han J; Sullivan DE; Searles TG; Preiss NK; Shabaneh TB; Zhang P; Hawkes AR; Malik BT; Kolling FW; Usherwood EJ; Wong SL; Phillips JD; Shirai K; Angeles CV; Yan S; Curiel TJ; Huang YH; Cheng C; Turk MJ Immunity; 2021 Sep; 54(9):2117-2132.e7. PubMed ID: 34525340 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells. Lengagne R; Le Gal FA; Garcette M; Fiette L; Ave P; Kato M; Briand JP; Massot C; Nakashima I; Rénia L; Guillet JG; Prévost-Blondel A Cancer Res; 2004 Feb; 64(4):1496-501. PubMed ID: 14973052 [TBL] [Abstract][Full Text] [Related]
16. Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases. Lengagne R; Graff-Dubois S; Garcette M; Renia L; Kato M; Guillet JG; Engelhard VH; Avril MF; Abastado JP; Prévost-Blondel A J Immunol; 2008 Jan; 180(1):130-7. PubMed ID: 18097012 [TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma. Sevko A; Sade-Feldman M; Kanterman J; Michels T; Falk CS; Umansky L; Ramacher M; Kato M; Schadendorf D; Baniyash M; Umansky V J Invest Dermatol; 2013 Jun; 133(6):1610-9. PubMed ID: 23223128 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines. Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520 [TBL] [Abstract][Full Text] [Related]
20. CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow. Parretta E; Cassese G; Barba P; Santoni A; Guardiola J; Di Rosa F J Immunol; 2005 Jun; 174(12):7654-64. PubMed ID: 15944266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]